Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hofseth International is a vertically integrated Norwegian seafood and biotechnology group. While primarily known as a major processor of Atlantic salmon, the company has established a significant presence in the life sciences sector through its subsidiary, Hofseth BioCare. Utilizing a proprietary enzymatic hydrolysis process, the company converts salmon offcuts into high-purity bioactive ingredients including peptides, marine collagen, and specialized oils. These products are supported by clinical research targeting indications such as iron deficiency anemia, inflammatory bowel disease, and respiratory health. Hofseth International manages the entire value chain from sustainable aquaculture to pharmaceutical-grade manufacturing and global distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hofseth International.